Customizing clinical decision support to prevent excessive drug-drug interaction alerts

American Journal of Health-System Pharmacy

Volumn 68, Issue 8, 2011, Pages 662-664

  Horn, John R ^a,b   Hansten, Philip D ^c   Osborn, Jacqueline D ^d   Wareham, Pamela ^d   Somani, Shabir ^c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c U of WI School of Pharmacy   (United States)

^d UW Medicine Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4 INHIBITOR; ENZYME INHIBITOR; UNCLASSIFIED DRUG;

CLINICAL DECISION MAKING; COMPUTER PROGRAM; DRUG CLASSIFICATION; DRUG INTERACTION; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; ELECTRONIC PRESCRIBING; HEALTH SERVICE; HOSPITAL BED; MORBIDITY; MORTALITY; PATIENT SAFETY; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; REVIEW; WORKFLOW;

EID: 79956053319     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100465     Document Type: Review

References (16)

1. Riechelmann RP, Zimmermann C, Chin SN et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage. 2008; 35:535-43.
2. Nobili A, Pasina L, Tettamanti M et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009; 34:377-86.
3. Moura C, Acurcio F, Belo N. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009; 12:266-72.
4. Weingart SN, Simchowitz B, Padolsky H et al. An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care. Arch Intern Med. 2009; 169:1465-73.
5. Cash JJ. Alert fatigue. Am J Health-Syst Pharm. 2009; 66:2098-101.
6. Hazlet TK, Lee TA, Hansten PD et al. Performance of community pharmacy drug interaction software. J Am Pharm Assoc. 2001; 41:200-4.
7. Abarca J, Colon LR, Wang VS et al. Evaluation of performance of drug-drug interaction screening software in community and hospital pharmacies. J Manag Care Pharm. 2006; 12:383-9. (Pubitemid 47400595)
8. Van der Sijs H, Aarts J, Vulto A et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006; 13:138-47. (Pubitemid 43332904)
9. Issac T, Weissman JS, Davis RB et al. Overrides of medication alerts in ambulatory care. Arch Intern Med. 2009; 169:305-11.
10. Weingart SN, Toth M, Sands DZ et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003; 163:2625-31. (Pubitemid 37464421)
11. Chaffee BW, Zimmerman CR. Developing and implementing clinical decision support for use in a computerized prescriber-order-entry system. Am J Health-Syst Pharm. 2010; 67:391-400.
12. Van der Sijs H, Aarts J, van Gelder T et al. Turning off frequently overridden drug alerts: limited opportunities for doing it safely. J Am Med Inform Assoc. 2008; 15:439-48. (Pubitemid 351885159)
13. Ko Y, Malone DC, D'Agostino JV et al. Potential determinants of prescribers' drug-drug interaction knowledge. Res Social Admin Pharm. 2008; 4:355-66.
14. Hansten PD, Horn JR, Hazlet TK. ORCA: operational classification of drug interactions. J Am Pharm Assoc. 2001; 41:161-5.
15. Hansten PD, Horn JR. Drug interactions analysis and management: a clinical perspective and analysis of current developments. St. Louis: Wolters Kluwer Health; 2010.
16. Hansten PD, Horn JR. The top 100 drug interactions: a guide to patient management, Freeland, WA: H&H; 2010.